TABLE 3.
Comparison between patients in whom gastrostomy was recommended and not performed, and those who underwent gastrostomy insertion.
| Parameter | Gastrostomy recommended | Gastrostomy performed |
|---|---|---|
| Diagnosis |
6 MSA 11 PSP 6 CBS |
7 MSA 11 PSP 3 CBS |
| Sex | 11F, 12M | 11F, 10M |
| Age at symptom onset (years) | 63.3 (8.1) | 60.9 (7.9) |
| Duration at baseline (years) | 4.8 (2.3) | 5.3 (3.3) |
| Total MDS‐UPDRS‐II at baseline | 27.3 (10.6) | 26.9 (10.3) |
| SEADL at baseline (%) | 50 (range 10–90) | 50 (range 10–90) |
| SEADL at gastrostomy recommendation (%) | 20 (range 10–50) | 20 (range 10–90) |
| MoCA at gastrostromy recommendation | 19.2 (6.4) | 23.7 (4.5)* |
Abbreviations: CBS, corticobasal syndrome; MDS‐UPDRS‐II, Movement Disorder Society‐Unified Parkinson's Disease Rating Scale‐Part II; MoCA, Montreal Cognitive Assessment; MSA, multiple system atrophy; PSP, progressive supranuclear palsy; SEADL, Schwab and England Activities of Daily Living Scale.
*
p < 0.05 compared with gastrostomy recommended.